Joint Filer Information
Name: | Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., Deerfield Private Design Fund IV, L.P. and Deerfield Partners, L.P. |
Address: | 780 Third Avenue, 37th Floor New York, NY 10017 |
Designated Filer: | James E. Flynn |
Issuer and Ticker Symbol: | Revolution Medicines, Inc. [RVMD] |
Date of Event Requiring Statement: | February 18, 2020 |
The undersigned, Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., Deerfield Private Design Fund IV, L.P. and Deerfield Partners, L.P. are jointly filing the attached Statement of Changes in Beneficial Ownership on Form 4 with James E. Flynn with respect to the beneficial ownership of securities of Revolution Medicines, Inc..
DEERFIELD MGMT, L.P. By: J.E. Flynn Capital, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
| DEERFIELD PRIVATE DESIGN FUND IV, L.P. By: Deerfield Mgmt IV, L.P., General Partner By: J.E. Flynn Capital IV, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
|
DEERFIELD MGMT IV, L.P. By: J.E. Flynn Capital IV, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
| |
DEERFIELD MANAGEMENT COMPANY, L.P. By: Flynn Management LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
| |
DEERFIELD PARTNERS, L.P. By: Deerfield Mgmt, L.P., General Partner By: J.E. Flynn Capital, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
|